| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Alexander Vinks, PhD |
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program |
Ntl Inst of Child Health & Human Dev National Institues of Health (NIH) |
T32HD069054 |
5/1/2020-4/30/2021 |
$203,508 |
| Alexander Vinks, PhD |
Pharmacogenetics of Oxycodone, Personalized Care and Persistent Surgical Pain |
Indiana University Health (Ntl Inst of Child Health & Human Dev) National Institues of Health (NIH) |
R01HD089458 |
9/1/2019-8/31/2020 |
$45,189 |
| Alexander Vinks, PhD |
EHR-embedded decision support platform for individualized precision drug treatment in neonates |
The Gerber Foundation |
Gerber |
10/1/2020-7/31/2022 |
$117,998 |
| Alexander Vinks, PhD |
First-In-Human Study of a Humanzied Anti-Cocaine Monoclonal Antibody |
University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) |
012264-003 |
5/1/2020-4/30/2021 |
$69,062 |
| Total Annual Grant Award Dollars |
$435,757 |
